Horn, DO, MPH, DABOM, MFOMA, medical director at the University of Texas Center for Obesity Medicine and Metabolic Performance and clinical assistant professor in the department of surgery at University of Texas McGovern Medical School in Houston, said the weight loss observed in ATTAIN-2 was lower than what was observed in ATTAIN-1, but added that adults with type 2 diabetes usually lose less weight with obesity pharmacotherapy than the nondiabetes population
This article provides a summary of the weight reduction effectiveness, glycemic control, and safety of semaglutide (up to a 2.4-mg dose) and tirzepatide (up to a 15-mg dose), with a focus on the Semaglutide Treatment Effect in People with Obesity (STEP) 2, SURPASS-1, and SURPASS-2 trials, which involved patients with type 2 diabetes mellitus
Inspect and store: Ensure a clear solution, label the vial with date, concentration, and peptide name
We serve all 50 states, and our credential-verification process confirms prescriber licensure matches your state's standards
The variable doing the most work for your daily energy expenditure isnt your formal cardio sessions
Chlorhexidine loaded nanomaterials for dental plaque control: enhanced antibacterial activity and biocompatibility
